2018 Awards

2018 SEBIO Award Finalists Announced

Over the past two decades, the Southeast has seen an increasing number of startups and venture capital investments. This maturation of the regional startup ecosystem has been spurred by an increase in notable exits and an increased focus and commitment from universities, state legislatures, local government and local financiers.

Annually, SEBIO recognizes best in class deals by the region’s biomedical companies in five categories: Public Offering, Strategic Acquisition, Strategic Investment, Venture Funding and Initial Venture Funding. The winners of the 2018 SEBIO awards were announced at the 20th Annual SEBIO conference on November 14, during lunch. Please join us in congratulating these companies for their achievements.

Finalists: Strategic Acquisition

K2M develops and manufactures a variety of implants, instruments, and disposables for the treatment of spinal pathologies. This Virginia-based company announced in August its acquisition by Stryker for $1.4 billion.

Halyard sold its Surgical & Infection Control business to Owens & Minor for $710mm to finance continued growth of its core medical device business, with the company rebranded as Avanos Medical in mid-2018 and remains in Alpharetta.